عربي

← All members · Key votes

H.Res. 803 · 119th Congress

Urging the Director of the Food and Drug Administration to reevaluate the safety of all chemical abortion drugs in light of recent independent studies, and for other purposes.

Introduced / in committeeHealth

Details

Sponsor
John W. Rose (R)
Introduced
2025-10-10
Origin
House
Policy area
Health
Latest action
2025-10-10 — Referred to the House Committee on Energy and Commerce.
Cosponsors
11

congress.gov

Summary

No official CRS summary yet.